脑部放疗，上午比下午敏感许多！
( {- F6 x( y" f, x+ j# v; A# {# @ l- p2 I9 {9 s, ^
s1 D# @, ?+ h0 Q @; D/ WCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
+ L7 `6 e0 k+ N1 YGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
, f4 d" [; s* j* E U+ O0 H4 j* |Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.- F4 ^! ?$ Y a8 P2 D- j/ q- U
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
9 G* o& Q! @) l! W
2 `7 T7 D3 E0 ^Abstract
) v8 p, q8 H- |9 B/ G2 mBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time., R: y+ Z, ^: v# \/ V2 V O
2 t$ k6 `7 Q! \ ~2 l/ a: HMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic." [% N1 W9 a4 s" S2 i, P3 Y2 k
1 q- K @% {: ?9 y7 f. t6 N4 N
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026)./ \1 T& S" m9 ?4 n! Y- C
. ^1 h1 E/ q# ^& U. p9 S$ ]0 ^$ KCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
4 {- n& T5 M/ D" f2 G) W! m7 y, Q3 g" c7 F
|
显身卡
